Sensyne Health Begins Trading on AIM

The video discusses the use of anonymized patient data in healthcare, highlighting its role in improving clinical trials and accelerating medical research. It addresses the global demand for such data, ethical considerations, and the potential use of blockchain for data security. A case study on pregnancy and diabetes illustrates practical applications. The video also covers investor interest in the UK health tech sector, emphasizing the strengths of the NHS and AI. Finally, it explores the impact of Brexit on business uncertainty, particularly in biotechnology and aerospace.

How does the use of anonymized data maintain public confidence in medical research?

What role does the NHS play in creating a strong health tech sector in the UK?

What challenges does Brexit pose for biotechnology companies in the UK?